Acadia Pharmaceuticals, Inc. <ACAD.O>: Oppenheimer raises target price to $25 from $23
ACAD•Related News
Covista names Scott Liles chief strategy and performance officer
CVSA•
Ethan Allen investor Bergeron nominates six directors, presses for strategy reset to restore growth at 2026 annual meeting
ETD•
Ball Corp raises target price to $66 from $65
BALL•
DuPont de Nemours, Inc. <DD.N>: UBS raises target price to $178 from $175
DD•
CrowdStrike launches USD 100,000 AI security challenge with AWS
CRWD•